EUVIMEDEUVIMED entdecken
Crossref

Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study

Frédéric Baron iD, Arnon Nagler iD, Jacques-Emmanuel Galimard, Jaime Sanz, Jurjen Versluis, Edouard Forcade iD, Patrice Chevallier iD, Anne Sirvent, Chloe Anthias, Jürgen Kuball, Sabine Furst, Alessandro Rambaldi und 12 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Frédéric Baron und 23 weiteren Autor:innen. Beteiligte Einrichtung: GIGA-I3, Université de Liège et CHU de Liège, Liège, Belgium. Hauptthemen laut MEDLINE: Cord Blood Stem Cell Transplantation, Leukemia, Myeloid, Acute, Hematopoietic Stem Cell Transplantation, Neoplasms, Second Primary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Fonds De La Recherche Scientifique - FNRS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated whether secondary versus de novo acute myeloid leukaemia (AML) would be associated with poor outcomes in adult acute AML patients in first complete remission (CR1) receiving unrelated cord blood transplantation (CBT). This is a retrospective study from the acute leukaemia working party of the European Society for Blood and Marrow Transplantation. Inclusion criteria included adult at first allogeneic haematopoietic cell transplantation between 2000 and 2021, unrelated single or double unit CBT, AML in CR1, no ex vivo T‐cell depletion and no post‐transplant cyclophosphamide. The primary end‐point of the study was leukaemia‐free survival (LFS). A total of 879 patients with de novo ( n = 696) or secondary ( n = 183) AML met the inclusion criteria. In multivariable analyses, sAML patients had non‐significantly different LFS (HR = 0.98, p = 0.86), overall survival (HR = 1.07, p = 0.58), relapse incidence (HR = 0.74, p = 0.09) and non‐relapse mortality (HR = 1.26, p = 0.13) than those with de novo AML. Our results demonstrate non‐significantly different LFS following CBT in adult patients with secondary versus de novo AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cord Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteHematopoietic Stem Cell TransplantationNeoplasms, Second PrimaryGraft vs Host DiseaseAdultHumansRetrospective StudiesNeoplasm Recurrence, LocalTransplantation ConditioningReceptors, Complement 3b

Stichwörter der Autor:innen

AMLacute myeloid leukaemiacord blood transplantationde novosecondary

Substanzen

CR1 protein, humanReceptors, Complement 3b

Autor:innen und Institutionen

  • GIGA-I3, Université de Liège et CHU de Liège, Liège, Belgium.
  • Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat-Gan, Israel.
  • EBMT Statistical Unit, Paris, France.
  • Department of Hematology, Saint Antoine Hospital, Paris, France.
  • INSERM UMR 938, Paris, France.
  • Sorbonne University, Paris, France.

ORCID-Profile: Frédéric Baron, Arnon Nagler, Edouard Forcade, Patrice Chevallier, Annalisa Ruggeri, Mohamad Mohty, Fabio Ciceri

Förderung

  • Fonds De La Recherche Scientifique - FNRS

Zitieren

APA

Baron, F., Nagler, A., Galimard, J. E., Sanz, J., Versluis, J., Forcade, E., Chevallier, P., Sirvent, A., Anthias, C., Kuball, J., Furst, S., Rambaldi, A., Sierra, J., von dem Borne, P. A., Gallego Hernanz, M. P., Cluzeau, T., Robinson, S., Raiola, A. M., Labussière-Wallet, H., …, & Ciceri, F. (2024). Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study. British Journal of Haematology. https://doi.org/10.1111/bjh.19130

Vancouver

Baron F, Nagler A, Galimard JE, Sanz J, Versluis J, Forcade E, et al. Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study. British Journal of Haematology. 2024. doi:10.1111/bjh.19130

BibTeX
@article{Baron2024,
  author = {Baron, Frédéric and Nagler, Arnon and Galimard, Jacques-Emmanuel and Sanz, Jaime and Versluis, Jurjen and Forcade, Edouard and Chevallier, Patrice and Sirvent, Anne and Anthias, Chloe and Kuball, Jürgen and Furst, Sabine and Rambaldi, Alessandro and Sierra, Jorge and von dem Borne, Peter A and Gallego Hernanz, Maria Pilar and Cluzeau, Thomas and Robinson, Stephen and Raiola, Anna Maria and Labussière-Wallet, Hélène and Byrne, Jenny L and Malfuson, Jean-Valère and Ruggeri, Annalisa and Mohty, Mohamad and Ciceri, Fabio},
  title = {Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19130}
}
Kostenlos starten →